Mylan N.V. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
535.5 M |
Public Float |
- |
Mylan N.V. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.46 |
Market Cap |
$10.05 B |
Shares Outstanding |
515.47 M |
Public Float |
513 M |
Address |
Building 4 Hatfield Hertfordshire AL10 9UL United Kingdom |
Employees | - |
Website | http://mylan.co.uk |
Updated | 07/08/2019 |
Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe, Rest of World, and Corporate or Other. |